SUNOVION PHARMACEUTICALS EUROPE LTD.23 August 2021
SUNOVION PHARMACEUTICALS EUROPE LTD2 April 2013
DAINIPPON SUMITOMO PHARMA EUROPE LTD.2 April 2013
SUMITOMO PHARMACEUTICALS EUROPE LIMITED3 April 2006
FAQs
Frequently Asked Questions
Detailed answers about CNX THERAPEUTICS LIMITED, including incorporation, status, business activity, and accounts information.
When was CNX THERAPEUTICS LIMITED founded?
CNX THERAPEUTICS LIMITED was officially incorporated on 1 May 1997 and is registered under company number 03363032. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CNX THERAPEUTICS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of CNX THERAPEUTICS LIMITED?
CNX THERAPEUTICS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CNX THERAPEUTICS LIMITED do?
CNX THERAPEUTICS LIMITED operates in the following sector: 46460 - Wholesale of pharmaceutical goods. This provides insight into the company's primary business activity and industry focus.
What is CNX THERAPEUTICS LIMITED's registered address?
The registered office address of CNX THERAPEUTICS LIMITED is 3 BUNHILL ROW, LONDON, ENGLAND, EC1Y 8YZ. This is the official address filed with Companies House for legal and statutory correspondence.
Is CNX THERAPEUTICS LIMITED financially stable?
The most recent accounts for CNX THERAPEUTICS LIMITED were made up to 31 March 2025, filed as FULL. Next accounts are due by 31 December 2026.
Does CNX THERAPEUTICS LIMITED have any charges or mortgages?
CNX THERAPEUTICS LIMITED has 2 registered charges, of which 1 is outstanding, 1 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.
Has CNX THERAPEUTICS LIMITED changed its name?
Yes, CNX THERAPEUTICS LIMITED has had 4 previous names: SUNOVION PHARMACEUTICALS EUROPE LTD. (changed 23 August 2021), SUNOVION PHARMACEUTICALS EUROPE LTD (changed 2 April 2013), DAINIPPON SUMITOMO PHARMA EUROPE LTD. (changed 2 April 2013), SUMITOMO PHARMACEUTICALS EUROPE LIMITED (changed 3 April 2006).